TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 150 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q4 2016. The put-call ratio across all filers is 2.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
Q4 2017 | $11,000 | -8.3% | 104 | 0.0% | 0.00% | -20.0% |
Q3 2017 | $12,000 | 0.0% | 104 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $12,000 | +20.0% | 104 | +5.1% | 0.01% | +25.0% |
Q1 2017 | $10,000 | +233.3% | 99 | +241.4% | 0.00% | +300.0% |
Q4 2016 | $3,000 | – | 29 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |